HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

532.388

+13.1152.53%

Number of Gainers:25

Number of Losers:5

Number of Flat:3

PE:- -

High:536.046

Open:518.785

Low:509.785

Close:519.273

Volume:108.28M

Turnover:3.89B

Market Cap:337.79B

Float Cap:301.32B

Loading ...

Does Long Term Trial Data Change The Bull Case For RemeGen Stock (SEHK:9995)?

Simply Wall St.

October Golden Stock Picks from Brokerages Revealed, Covering Pharmaceuticals, Information Technology, and More; WuXi AppTec and Zhongji Innolight Receive the Most Recommendations (List)

AH Premium Statistics: October 1

Everest Medicines Stock In Focus After China Approval For CARDAMYST

Simply Wall St.

Two Active Equity Funds Double Returns Exceeding 110%! First Three Quarters Active Equity Fund Performance Rankings Released

Pre-Holiday Gains: Can This Strong Sector Keep Rising After the Break?

China Pharma Sector Divergence Deepens as Innovative Drug Leaders Ride BD Second Growth Curve

Guo Huaqing Steps Down as Non-Executive Director of CARsgen-B (02171)

Transcenta Holding Pharmaceuticals-B Grants 30,000 New Award Shares Under Share Incentive Plan

CanSino Biologics (06185) A-Shares See Abnormal Trading Fluctuation, No Undisclosed Material Information to Be Disclosed

Hong Kong Stocks Close Higher as Property Stimulus Fails to Enthuse; Pharma Emerges as Safe Haven

A-Shares Waver as Property Stocks Surge on Mortgage Subsidy, Pharma Leads All Day with Hong Kong Medical ETF Index Up 4%

Pharma stocks lead all day as giants ramp up AI drug discovery bets; a double-bagger hits a fresh high again! Hong Kong Stock Connect Healthcare ETF (159137) touches a stage peak, underlying index climbs 4%

Pre-Holiday Rally: Can This Strong Sector Continue to Rise After the Break?

ANTENGENE-B (06996) Spends HK$304,500 to Repurchase 88,000 Shares on September 30

Pharma Stocks Surge on Final Trading Day Before Holiday

Should Phase III Cancer Trial Win Require Action From Akeso Stock Investors?

Simply Wall St.

ETF Daily Report (09.30): ESMO Data Expectations and BD Momentum Lift Vaccine and Innovative Drug Sectors, Semiconductor Stocks Retreat Broadly

Huiyu Pharmaceutical's Paclitaxel Injection (Albumin-Bound) Secures Overseas Marketing Authorization

RemeGen Biotech Shares Rise Over 3% in Late Trading; Telitacicept gMG China Phase III Analysis Results Presented at AANEM Annual Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BK1574/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":532.3884,"timestamp":1790755705764,"preClose":519.27344,"halted":0,"volume":108281314,"delay":0,"changeRate":0.025256,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":13.11499,"latestTime":"09-30 16:00:00","open":518.7852,"high":536.04626,"low":509.7852,"amount":3894467673,"amplitude":0.050573,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"pbRate":3.967371,"peRate":176.437057,"turnoverRate":0.003973,"increases":27,"decrements":4,"flats":1,"marketCap":337786113504,"floatMarketCap":301319866336},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":536.04626,"amplitude":0.050573,"preClose":519.27344,"low":509.7852,"pbRate":"3.967371","latestPrice":532.3884,"volume":108281314,"delay":0,"open":518.7852,"prevYearClose":556.26263,"prevWeekClose":495.27,"prevMonthClose":532.388,"prevQuarterClose":532.388,"fiveDayClose":520.692,"twentyDayClose":501.553,"sixtyDayClose":496.318,"secType":"PLATE","market":"HK","turnoverRate":0.003973,"peRate":176.437057,"marketCap":337786113504,"floatMarketCap":301319866336,"timestamp":1790755705764,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":25,"down":5,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672475774","title":"Does Long Term Trial Data Change The Bull Case For RemeGen Stock (SEHK:9995)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672475774","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672475774?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:12","pubTimestamp":1790849562,"startTime":"0","endTime":"0","summary":"Vor Bio reported a post hoc analysis of RemeGen partner trial data in adults with generalized myasthenia gravis, showing that telitacicept produced deep, durable minimal symptom expression over 48 weeks with no new safety signals in a 114-patient Phase 3 study in China.\nThe analysis suggests telitacicept could matter commercially for RemeGen, with around 42% of treated participants achieving minimal symptom expression and many sustaining it over time, including those who started with higher...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/does-long-term-trial-data-change-the-bull-case-for-remegen-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/does-long-term-trial-data-change-the-bull-case-for-remegen-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","09995","BK1574","BK1583","LU2328871848.SGD","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169719280","title":"October Golden Stock Picks from Brokerages Revealed, Covering Pharmaceuticals, Information Technology, and More; WuXi AppTec and Zhongji Innolight Receive the Most Recommendations (List)","url":"https://stock-news.laohu8.com/highlight/detail?id=1169719280","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169719280?lang=en_us&edition=fundamental","pubTime":"2026-10-01 17:40","pubTimestamp":1790847626,"startTime":"0","endTime":"0","summary":"For stock trading, check the Golden Qilin analyst research reports — authoritative, professional, timely, and comprehensive, helping you uncover potential thematic opportunities! WuXi AppTec is the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1251922891.USD","BK1249","BK4585","LU0082770016.SGD","LU2488822045.USD","BK1576","KCE","LU2148510915.USD","LU0164865239.USD","LU0052750758.USD","LU2045819591.USD","IE00BYTNYN87.SGD","LU0611395673.USD","159938","LU0708995583.HKD","IE00BPRC5H50.USD","LU2495084118.USD","BK0167","LU2008162690.USD","LU0082770016.USD","LU0561508036.HKD","IE00B12V2V27.USD","91530","LU0164939612.USD","BK1515","LU0469268626.HKD","LU1046422090.SGD","BK0214","LU1969619763.USD","LU1997245094.SGD","LU1961090484.USD","LU0417516738.SGD","LU2580892862.HKD","LU0531971595.HKD","LU1794554557.SGD","LU0327786744.USD","03308","LU1655091616.SGD","BK1149","603259","LU2476274720.SGD","LU2242644610.SGD","LU2328871848.SGD","LU1255011170.USD","BK1141","SG9999011746.SGD","BK4588","LU0620787316.HKD","LU0540923850.HKD","02359","BK1574","LU1303224171.USD","BK0028","LU2177674079.SGD","LU0210526637.USD","LU2213484517.USD","BK0070","HK0000306685.HKD","BK0077","LU1146622755.USD","LU0320764599.SGD","LU1934453819.USD","LU2778985437.USD","LU1997244956.HKD","BK1533","LU0871576103.HKD","BK1122","LU1023057109.AUD","ARKG","LU0039217434.USD","LU1808992512.USD","HK0000320223.HKD","IE00B5MMRT66.SGD","LU1820825898.SGD","LU0359202008.SGD","LU0456827905.SGD","BK1583","09939","LU0359201612.USD","LU1719994722.HKD","IE00BYQNZ168.SGD","300308","LU0348767384.USD","SGXZ81163826.USD","LU1770034418.SGD","LU0231483743.USD","LU1206782309.USD","LU2125910500.SGD","LU0051755006.USD","BK0216","LU2580892789.USD","IE00B543WZ88.USD","LU1781817850.SGD","LU0348825331.USD","LU0348766576.USD","LU2289578879.USD","BK4544","IE0034224299.USD","LU1979443071.USD","BK1161","LU0700851271.USD","LU0348735423.USD","LU1064130708.USD","LU1997245177.USD","LU2399975544.HKD","LU0634319403.HKD","SGXZ49509284.SGD","HK0000306701.USD","LU0348827113.USD","LU2476274308.USD","LU0456842615.SGD","LU0417516902.SGD","LU1580142542.USD","LU1720050803.USD","LU0359201885.HKD","VGT","LU1064131003.USD","LU0572944931.SGD","HK0000320264.USD","159939","IE0032431581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151237778","title":"AH Premium Statistics: October 1","url":"https://stock-news.laohu8.com/highlight/detail?id=1151237778","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151237778?lang=en_us&edition=fundamental","pubTime":"2026-10-01 16:21","pubTimestamp":1790842887,"startTime":"0","endTime":"0","summary":"As of the close on October 1, NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and HOLLY FUTURES (03678) ranked as the top three in AH premium rates, at 1155.81%, 390.84%, and 336.74% respectively.CATL...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1183","LU0737861772.HKD","LU0886674414.USD","LU0106252389.USD","SG9999011746.SGD","399300","BK1161","03968","BK1249","BK1202","02899","LU2045819591.USD","LU0211977185.USD","LU0737861699.HKD","LU2097828714.EUR","HK0000352291.HKD","IE00B29SXG58.USD","01812","LU0348766576.USD","LU1988902786.USD","LU2476274308.USD","03986","83130","LU0315179316.USD","LU0348827113.USD","LU0348735423.USD","82846","IE00B5MMRT66.SGD","LU0648948544.HKD","IE00BZ08YR35.GBP","LU1794554557.SGD","LU0165289439.USD","LU2097828631.EUR","LU0417516738.SGD","LU2097828557.USD","LU0164865239.USD","82823","BK1105","LU0307460666.USD","159982","LU1282649141.HKD","LU1719994722.HKD","LU0871576103.HKD","IE00BVYPNP33.GBP","SG9999006597.SGD","LU0918141705.HKD","02238","LU0314109678.HKD","LU2242644610.SGD","LU0431992006.USD","BK1116","LU0029875118.USD","LU1206782309.USD","LU1688375341.USD","LU0797268264.HKD","82843","BK1181","BK1576","HK0001040168.HKD","HK0000320264.USD","02822","IE00B543WZ88.USD","LU0449509016.USD","01187","LU0456854461.SGD","LU1880383440.USD","IE0031814852.USD","LU0823426480.USD","LU0072913022.USD","LU1770034418.SGD","LU0149721374.USD","LU1366334578.USD","LU0370786039.SGD","LU0320764755.SGD","LU0540923850.HKD","02843","LU0054450605.USD","BK1592","02338","LU0791590937.USD","LU0463099449.HKD","LU0345780521.USD","BK1171","LU0561508036.HKD","LU2294711473.HKD","02691","IE0032431581.USD","LU1064131342.USD","LU0449515922.USD","03143","BK1130","LU1251922891.USD","HK0000320223.HKD","IE00BZ08YT58.USD","BK1125","83188","06127","LU0117841782.USD","03996","LU1244550494.USD","BK1148","LU0052750758.USD","LU0531971595.HKD","LU1960683339.HKD","BK1223","LU0516422440.USD","02846","LU1807302812.USD","LU0634319403.HKD","02827","BK1610","LU2125910500.SGD","LU0067412154.USD","LU2264538146.SGD","LU1105468828.SGD","06821","LU0244354667.USD","SG9999001226.SGD","LU0862451753.SGD","IE00BMCWC346.EUR","LU0828237510.HKD","BK1521","LU0164939612.USD","LU1328277881.USD","LU1769817179.HKD","LU1211504680.USD","LU0880133367.SGD","LU0039217434.USD","EWH","00568","HK0000252160.HKD","LU1115378108.SGD","BK1505","HK0000306685.HKD","IE00BVYPNQ40.USD","LU2778985437.USD","LU0469268626.HKD","LU3063872942.SGD","HK0001040143.USD","02245","00811","LU0329678337.USD","01057","LU0173614495.USD","LU0918141887.USD","BK1122","LU0516422366.SGD","LU0164880469.USD","LU0048580855.USD","03750","SG9999004220.SGD","LU0348825331.USD","BK1198","03130","LU0229945570.USD","BK1100","00317","BK1558","LU0096374516.USD","LU0384037296.USD","00699","LU2177674079.SGD","LU0359202008.SGD","LU2476274720.SGD","BK1539","LU1242518857.USD","LU0348788117.USD","LU1961090484.USD","LU0890818403.SGD","LU0061477393.USD","LU0082770016.USD","IE00B031J352.USD","BK1190","LU0106959298.USD","IE0008369823.USD","IE00BGHQDM52.EUR","LU0488056044.USD","LU0589944569.HKD","LU1813983027.USD","HK0000500386.USD","BK1144","LU0348814723.USD","LU0348767384.USD","BK1522","BK1191","LU0509642566.USD","BK1554","LU1242518931.SGD","BK1147","LU1504937902.USD","BK1170","02823","LU0228659784.USD","LU1282649810.SGD","LU0329678170.USD","BK1149","SG9999002828.SGD","BK1583","LU1366334651.USD","SG9999014674.SGD","01349","BK1515","02359","LU0254981946.USD","BK1507","LU2097828805.USD","BK1562","02218","LU0328353924.USD","LU0588546209.SGD","LU2039709279.SGD","IE0034224299.USD","00042","BK1533","BK1530","LU0320764599.SGD","LU0051755006.USD","BK1564","BK1544","LU0348805143.USD","LU0287142896.SGD","LU0210526637.USD","LU1769817096.USD","LU0828237940.HKD","BK1237","LU2008162690.USD","LU1831875114.USD","LU2097828474.EUR","LU0607220059.USD","LU0543330566.HKD","LU1675838814.USD","LU0214875030.USD","LU0593848301.USD","LU0140636845.USD","BK1163","LU0327786744.USD","LU1048596156.SGD","LU0231483743.USD","LU1655091616.SGD","SG9999002463.SGD","LU1224709979.USD","LU0348816934.USD","06185","01108","BK1119","BK1193","LU0149534421.HKD","IE00BZ08YS42.EUR","LU0502904849.HKD","LU0269904917.USD","02865","LU0572944931.SGD","BK1560","IE0008368742.USD","LU0868486357.SGD","LU0708995583.HKD","LU1226287529.USD","LU0359201612.USD","LU0501845795.SGD","BK1574","03308","LU0128522157.USD","LU0417516902.SGD","BK1141","LU1808992512.USD","06951","LU1282648689.USD","LU2399975544.HKD","03328","LU0043850808.USD","LU1282649067.USD","LU1244550221.USD","BK1546","LU1303224171.USD","LU1255011170.USD","LU0821914370.USD","IE00B031HY20.USD","BK1551","LU1152091168.USD","LU0082770016.SGD","82822","LU0516422952.EUR","LU1023057109.AUD","LU0359201885.HKD","LU1046422090.SGD","LU0620787316.HKD","LU0543330483.HKD","HK0000352382.USD","LU1188198961.HKD","LU2226246903.HKD","IE00B3M56506.USD","LU0516423174.USD","LU0049853897.USD","BK1110","06067","LU0979878070.USD","LU1244550577.SGD","BK1594","02475","LU1993786604.SGD","BK1231","LU0791591158.USD","LU1481107354.HKD","09976","01033","LU0456827905.SGD","LU0455707207.USD","LU0266512473.USD","LU1152091754.HKD","LU0640798160.USD","LU0516423091.SGD","LU0828238088.HKD","LU0531970944.HKD","SG9999001093.SGD","03200","LU0266512127.USD","IE00BYV24P56.USD","03188","IE00BF5LJ272.USD","LU0456846285.SGD","LU0672654166.SGD","LU1880383366.USD","00916","07233","00553","LU0345780281.USD","HK0000252152.HKD","LU0823426308.USD","LU0181495838.USD","HK0000306701.USD","BK1154","LU0228367735.SGD","00991","BK1514","LU1720050803.USD","LU0326950275.SGD","LU0823040885.USD","LU0163747925.USD","03678","LU1008478684.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672755958","title":"Everest Medicines Stock In Focus After China Approval For CARDAMYST","url":"https://stock-news.laohu8.com/highlight/detail?id=2672755958","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672755958?lang=en_us&edition=fundamental","pubTime":"2026-10-01 16:17","pubTimestamp":1790842633,"startTime":"0","endTime":"0","summary":"Everest Medicines has secured NMPA approval in China for CARDAMYST, a self-administered etripamil nasal spray for acute PSVT episodes, supported by multiple studies showing rapid rhythm conversion, at-home use, and generally mild side effects.\nThe launch of CARDAMYST as Everest Medicines' first cardiovascular therapy moves the business into a new treatment area with a large PSVT and AFib RVR patient pool across Greater China.\nWe will now look at how Everest Medicines' investment narrative...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1952/everest-medicines-shares/news/everest-medicines-stock-in-focus-after-china-approval-for-ca","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1952/everest-medicines-shares/news/everest-medicines-stock-in-focus-after-china-approval-for-ca","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","BK1161","BK1574","01952","MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118846740","title":"Two Active Equity Funds Double Returns Exceeding 110%! First Three Quarters Active Equity Fund Performance Rankings Released","url":"https://stock-news.laohu8.com/highlight/detail?id=1118846740","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118846740?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:20","pubTimestamp":1790832030,"startTime":"0","endTime":"0","summary":"Technology stocks pulled back from highs, pharmaceutical stocks staged a strong rally, and the number of 'double-return funds' shrank significantly.The first three quarters of A-share trading have...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","09939","ARTY","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124333888","title":"Pre-Holiday Gains: Can This Strong Sector Keep Rising After the Break?","url":"https://stock-news.laohu8.com/highlight/detail?id=1124333888","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124333888?lang=en_us&edition=fundamental","pubTime":"2026-09-30 22:11","pubTimestamp":1790777476,"startTime":"0","endTime":"0","summary":"On September 30, the final trading day before the National Day holiday, A-shares staged a session of \"stable index but internal divergence.\" Throughout the day, the Shanghai Composite Index rose...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06978","MEDX","LNGR","BK1574","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193254159","title":"China Pharma Sector Divergence Deepens as Innovative Drug Leaders Ride BD Second Growth Curve","url":"https://stock-news.laohu8.com/highlight/detail?id=1193254159","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193254159?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:30","pubTimestamp":1790775022,"startTime":"0","endTime":"0","summary":"China's pharmaceutical sector is undergoing a structural revaluation.Under the dual pressures of ongoing anti-corruption campaigns and medical insurance cost containment, domestic drugmakers saw...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK1574","159938","09939","MEDX","06978","BK1161","BK1515","159992","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184326594","title":"Guo Huaqing Steps Down as Non-Executive Director of CARsgen-B (02171)","url":"https://stock-news.laohu8.com/highlight/detail?id=1184326594","media":"Stock News","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184326594?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:08","pubTimestamp":1790773704,"startTime":"0","endTime":"0","summary":"CARsgen-B (02171) has announced that Mr. Guo Huaqing has tendered his resignation as a non-executive director of the company.The resignation will take effect on September 30, 2026.The company stated...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02171","BK1587","BK1161","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167355707","title":"Transcenta Holding Pharmaceuticals-B Grants 30,000 New Award Shares Under Share Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1167355707","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167355707?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:07","pubTimestamp":1790773676,"startTime":"0","endTime":"0","summary":"Transcenta Holding Pharmaceuticals-B (06628) has issued an announcement that on September 30, 2026, in replacement of previously granted awards that were cancelled, the company granted 30,000 new...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","09939","BK1515","BK1574","BK1161","06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168776281","title":"CanSino Biologics (06185) A-Shares See Abnormal Trading Fluctuation, No Undisclosed Material Information to Be Disclosed","url":"https://stock-news.laohu8.com/highlight/detail?id=1168776281","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168776281?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:54","pubTimestamp":1790769269,"startTime":"0","endTime":"0","summary":"CanSino Biologics (06185) has issued an announcement that the company's A-shares experienced abnormal trading fluctuations, with the cumulative deviation of daily closing price gains exceeding 30%...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159982","02822","82823","06185","83130","02846","02843","399300","83188","82822","BK1147","02823","BK1191","BK1161","03188","07233","82843","02827","BK1574","82846","BK1610","03130","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175830383","title":"Hong Kong Stocks Close Higher as Property Stimulus Fails to Enthuse; Pharma Emerges as Safe Haven","url":"https://stock-news.laohu8.com/highlight/detail?id=1175830383","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175830383?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:52","pubTimestamp":1790769171,"startTime":"0","endTime":"0","summary":"Market sentiment was sluggish through late September, but policy support announced yesterday helped steady the mood. Hong Kong stocks opened lower before climbing, closing up 0.37%.Talks between the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1514","BK1191","BK1574","KCAI","BK1109","01081","01276","BK1576","BK1123","BK1161","BK4588","BK1205","09939","02556","LU0359201885.HKD","LU2543165471.USD","BK4585","BK1505","VXUS","BK1561","LU0359202008.SGD","BK1515","LU1023057109.AUD","BK1141","00753","BK1618","BK1518","LU0359201612.USD","06127","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122335629","title":"A-Shares Waver as Property Stocks Surge on Mortgage Subsidy, Pharma Leads All Day with Hong Kong Medical ETF Index Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1122335629","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122335629?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:20","pubTimestamp":1790767248,"startTime":"0","endTime":"0","summary":"China's three major A-share indices moved within a narrow range today (September 30). By the close, the Shanghai Composite rose 0.31% to 3,842.19 points, while the Shenzhen Component fell 0.11% and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["82823","FLHK","09939","02843","82843","159828","03188","07233","BK1610","BK1515","02827","BK1147","399300","02846","82822","03130","83130","02823","02822","159982","159938","BK1161","BK1574","83188","159137","82846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186165063","title":"Pharma stocks lead all day as giants ramp up AI drug discovery bets; a double-bagger hits a fresh high again! Hong Kong Stock Connect Healthcare ETF (159137) touches a stage peak, underlying index climbs 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186165063","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186165063?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:10","pubTimestamp":1790766652,"startTime":"0","endTime":"0","summary":"On the final trading day of September, A-share and Hong Kong pharma stocks surged together to close out the period! A-share pharma and biotech led all sectors, with the underlying indices of the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","159137","QTOC","FLHK","BK1161","BK1574","159828","CHAT","01477","09939","VTHR","AGIX","ARTY","159938","BK1191","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115768798","title":"Pre-Holiday Rally: Can This Strong Sector Continue to Rise After the Break?","url":"https://stock-news.laohu8.com/highlight/detail?id=1115768798","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115768798?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:31","pubTimestamp":1790764261,"startTime":"0","endTime":"0","summary":"For stock trading, see the Golden Qilin analyst research reports — authoritative, professional, timely, and comprehensive, helping you uncover potential thematic opportunities!On September 30, the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","IBBQ","BK1574","06978","BK1161","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165215811","title":"ANTENGENE-B (06996) Spends HK$304,500 to Repurchase 88,000 Shares on September 30","url":"https://stock-news.laohu8.com/highlight/detail?id=1165215811","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165215811?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:28","pubTimestamp":1790764098,"startTime":"0","endTime":"0","summary":"ANTENGENE-B (06996) has announced that on September 30, 2026, it spent HK$304,500 to repurchase 88,000 shares.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","BK1191","06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133719199","title":"Pharma Stocks Surge on Final Trading Day Before Holiday","url":"https://stock-news.laohu8.com/highlight/detail?id=1133719199","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133719199?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:50","pubTimestamp":1790761842,"startTime":"0","endTime":"0","summary":"September 30 marks the last trading day before the National Day holiday. Many expected the market to close quietly, but the opposite happened—semiconductors dropped 2.75%, while pharmaceutical stocks...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","BK1515","159938","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672384227","title":"Should Phase III Cancer Trial Win Require Action From Akeso Stock Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672384227","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672384227?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:20","pubTimestamp":1790760033,"startTime":"0","endTime":"0","summary":"Akeso reported that its bispecific antibody ivonescimab achieved statistically significant and clinically meaningful superiority in overall survival, progression free survival, and objective response rate versus a durvalumab based regimen in the Phase III HARMONi-GI1 biliary tract cancer trial, with full data selected for a Presidential Symposium at ESMO 2026.\nThe cluster of nearly 30 ESMO 2026 presentations on ivonescimab, cadonilimab, and early ADC assets, plus fresh Phase I clearance for...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/should-phase-iii-cancer-trial-win-require-action-from-akeso","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/should-phase-iii-cancer-trial-win-require-action-from-akeso","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0348735423.USD","LU0561508036.HKD","BK1574","IE00B5MMRT66.SGD","IE00B543WZ88.USD","KURE","LU0348784397.USD","LU0417516738.SGD","LU2476274720.SGD","LU1720050803.USD","ISBC","LU2778985437.USD","LU0348766576.USD","LU2488822045.USD","LU1961090484.USD","LU0417516902.SGD","BK4211","LU2399975544.HKD","IE00BPRC5H50.USD","LU0348827113.USD","LU0348767384.USD","LU1794554557.SGD","LU0348825331.USD","LU0634319403.HKD","LU0540923850.HKD","BK1161","LU0348783233.USD","LU0417516571.SGD","09926","LU2476274308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131236520","title":"ETF Daily Report (09.30): ESMO Data Expectations and BD Momentum Lift Vaccine and Innovative Drug Sectors, Semiconductor Stocks Retreat Broadly","url":"https://stock-news.laohu8.com/highlight/detail?id=1131236520","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131236520?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:45","pubTimestamp":1790757941,"startTime":"0","endTime":"0","summary":"Hong Kong stocks posted collective gains on the day, with clear divergence across sectors, as pharmaceutical and biotechnology sectors outperformed while autos and semiconductors weakened. By the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CWC","IBBQ","SOXQ","159646","SSG","VGT","CHPS","BK4588","EIS","159582","MQQQ","TECY","FWD","CHPY","BK4585","PSI","SOXX","TEKX","SMHU","LNGR","MEDX","SMHX","06978","SOXL","BK1161","BK4550","XSD","SOXS","NBDS","BK1574","FTXL","SMH","BK4535","159992","FDN","SOXY","USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127907975","title":"Huiyu Pharmaceutical's Paclitaxel Injection (Albumin-Bound) Secures Overseas Marketing Authorization","url":"https://stock-news.laohu8.com/highlight/detail?id=1127907975","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127907975?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:12","pubTimestamp":1790755935,"startTime":"0","endTime":"0","summary":"Huiyu Pharmaceutical (688553.SH) announced that its subsidiary, Seacross (Europe) Pharma Ltd., recently received marketing authorization from the French National Agency for Medicines and Health...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","BK1191","BK0239","BK1574","688553","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142205216","title":"RemeGen Biotech Shares Rise Over 3% in Late Trading; Telitacicept gMG China Phase III Analysis Results Presented at AANEM Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1142205216","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142205216?lang=en_us&edition=fundamental","pubTime":"2026-09-30 15:54","pubTimestamp":1790754863,"startTime":"0","endTime":"0","summary":"RemeGen Biotech (09995) shares rose more than 3% in late trading, up 3.01% to HK$77.05 as of press time, with a turnover of HK$219 million.On the news front, according to RemeGen Biotech's official...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688331","LU1064131003.USD","BK0239","BK1574","KCAI","LU2488822045.USD","LU1064130708.USD","LU2328871848.SGD","LU1969619763.USD","BK1583","VXUS","09995","BK4585","LU2148510915.USD","BK1161","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}